Tumor perfusion rate determined noninvasively by dynamic computed tomography predicts outcome in head-and-neck cancer after radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 5, 2003, Pages 1351-1356

  Hermans, Robert ^a   Meijerink, Martijn ^a   Van Den Bogaert, Walter ^a   Rijnders, Alexis ^a   Weltens, Caroline ^a   Lambin, Philippe ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Computed tomography; Head and neck cancer; Hypoxia; Outcome; Perfusion

Indexed keywords

ANIMAL CELL CULTURE; CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; ONCOLOGY;

TUMOR PERFUSION RATES;

RADIOTHERAPY;

ANTINEOPLASTIC AGENT; CISPLATIN; CONTRAST MEDIUM; PORFIROMYCIN;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTERY; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DENSITY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INJECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PERFUSION; PREDICTION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0344394996     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00764-8     Document Type: Article

References (31)

1. Gray L.H., Conger A.D., Ebert M., , et al. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol. 26:1953;638-648.
2. Vaupel P, Kelleher DK, Hockel M. Oxygen status of malignant tumors: Pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28(Suppl. 8):S29-S35.
3. Stadler P., Becker A., Feldmann H.J., , et al. Influence of the hypoxic subvolume on the survival of patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 44:1999;749-754.
4. Brizel D.M., Dodge R.K., Clough R.W., , et al. Oxygenation of head and neck cancer Changes during radiotherapy and impact on treatment outcome . Radiother Oncol. 53:1999;113-117.
5. Nordsmark M., Overgaard J. A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol. 57:2000;39-43.
6. Wouters B.G., Weppler S.A., Koritzinsky M., , et al. Hypoxia as a target for combined modality treatments. Eur J Cancer. 38:2002;240-257.
7. Rubin P., Hanley J., Keys H., , et al. Carbogen breathing during radiation therapy The Radiation Therapy Oncology Group Study . Int J Radiat Oncol Biol Phys. 5:1979;1963-1970.
8. Fazekas J., Pajak T., Marcial V., , et al. The RTOG randomized trial (79-15) Misonidazole adjuvant to radiotherapy in advanced head and neck squamous cancers . Proc Am Soc Clin Oncol. 3:1984;185. (Abstr.).
9. Martin L., Lartigau E., Weeger P., , et al. Changes in the oxygenation of head and neck tumors during carbogen breathing. Radiother Oncol. 27:1993;123-130.
10. Becker A., Kuhnt T., Liedtke H., , et al. Oxygenation measurements in head and neck cancers during hyperbaric oxygenation. Strahlenther Onkol. 178:2002;105-108.
11. Kaanders J.H., Pop L.A., Marres H.A., , et al. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer. Radiother Oncol. 48:1998;115-122.
12. Kaanders J.H., Pop L.A., Marres H.A., , et al. ARCON Experience in 215 patients with advanced head-and-neck cancer . Int J Radiat Oncol Biol Phys. 52:2002;769-778.
13. Hermans R., Lambin P.h, Van der Goten A., , et al. Non-invasive tumour perfusion measurement by dynamic CT Preliminary results . Radiother Oncol. 44:1997;159-162.
14. Hermans R., Lambin P.h, Van der Goten A., , et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol. 53:1999;105-111.
15. Union International Contre le Cancer. TNM atlas. 3rd ed. 2nd Revision. Berlin: Springer; 1992.
16. Breiman R.S., Beck J.W., Korobkin M., , et al. Volume determinations using computed tomography. Am J Roentgenol AJR. 138:1982;329-333.
17. Maes A., Weltens C., Flamen P., , et al. Preservation of parotid function with uncomplicated conformal radiotherapy. Radiother Oncol. 63:2002;203-211.
18. Lartigau E., Le Ridant A.M., Lambin P.h, , et al. Oxygenation of head and neck tumors. Cancer. 71:1993;2319-2325.
19. Hermans R., Van den Bogaert W., Rijnders A., , et al. Predicting the local outcome of glottic squamous cell carcinoma after definitive radiation therapy Value of computed tomography-determined tumour parameters . Radiother Oncol. 50:1999;39-46.
20. Mancuso A.A., Mukherji S.K., Schmalfuss I., , et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol. 17:1999;631-637.
21. Pameijer F.A., Mancuso A.A., Mendenhall W.M., , et al. Evaluation of pretreatment computed tomography as a predictor of local control in T1/T2 pyriform sinus carcinoma treated with definitive radiotherapy. Head Neck. 20:1998;159-168.
22. Chua D.T., Sham J.S., Kwong D.L., , et al. Volumetric analysis of tumor extent in nasopharyngeal carcinoma and correlation with treatment outcome. Int J Radiat Oncol Biol Phys. 39:1997;711-719.
23. Nathu R.M., Mancuso A.A., Zhu T.C., , et al. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck. 22:2000;1-5.
24. Hermans R., Op de beeck K., Van den Bogaert W., , et al. The relation of CT-determined tumor parameters and local and regional outcome of tonsillar cancer after definitive radiation treatment. Int J Radiat Oncol Biol Phys. 50:2001;37-45.
25. Chao K.S.C., Bosch W.R., Mutic S., , et al. A novel approach to overcome hypoxic tumor resistance Cu-ATSM-guided intensity-modulated radiation therapy . Int J Radiat Oncol Biol Phys. 49:2001;1171-1182.
26. Römer W, Muresan L, Adamietz B, et al. Biological characterization and response monitoring in head and neck cancer therapy using multislice perfusion CT. Eur Radiol 2002;12(Suppl. 1):S193(Abstr.).
27. Million R.R., Cassisi N.J., Mancuso A.A., , et al. Management of the neck for squamous cell carcinoma. Million R.R., Cassisi N.J. Management of head and neck cancer: A multidisciplinary approach. 1994;125 J. B. Lippincott Company, Philadelphia.
28. Becker A., Hansgen G., Bloching M., , et al. Oxygenation of squamous cell carcinoma of the head and neck Comparison of primary tumors, neck node metastases, and normal tissue . Int J Radiat Oncol Biol Phys. 42:1998;35-41.
29. Larsson H.B., Studgaard M., Frederiksen J.L., , et al. Quantification of blood-brain barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med. 16:1990;117-131.
30. Tofts P.S., Kermode A.G. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. I. Fundamental concepts. Magn Reson Med. 17:1991;357-367.
31. Rijpkema M., Kaanders J.H.A.M., Joosten F.B.M., , et al. Method for quantitative mapping of dynamic MRI contrast agent uptake in human tumors. J Magn Reson Imaging. 14:2001;457-463.